Skip to main content

Ani Pharmaceuticals Inc

ANIP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001023024

In the last 90 days, Ani Pharmaceuticals Inc insiders filed 0 open-market purchases and 11 sales; 307 institutions reported holding it in 13F filings for Q2 2026, worth $1.90B in total; no superinvestor holds it.

13F holders, Q1 2025

Institutional positions in Ani Pharmaceuticals Inc as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
231
+28 vs. Q4 2024
Shares held
20.0M
+765.3K (+4.0%) vs. Q4 2024
Total value
$1.34B
+$272.8M (+25.6%) vs. Q4 2024
New holders
48
63 more added
Sold out
20
75 more reduced

3 institutions that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q4 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting ANIP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2025: 231 institutions
Q1 2021: 106 institutionsQ2 2021: 116 institutionsQ3 2021: 118 institutionsQ4 2021: 132 institutionsQ1 2022: 126 institutionsQ2 2022: 120 institutionsQ3 2022: 126 institutionsQ4 2022: 126 institutionsQ1 2023: 138 institutionsQ2 2023: 172 institutionsQ3 2023: 186 institutionsQ4 2023: 181 institutionsQ1 2024: 200 institutionsQ2 2024: 201 institutionsQ3 2024: 208 institutionsQ4 2024: 206 institutionsQ1 2025: 231 institutionsQ2 2025: 233 institutionsQ3 2025: 269 institutionsQ4 2025: 285 institutionsQ1 2026: 281 institutionsQ2 2026: 307 institutions
Value heldQ1 2025: $1.34B
Q1 2021: $263.5MQ2 2021: $252.7MQ3 2021: $238.8MQ4 2021: $413.4MQ1 2022: $258.8MQ2 2022: $293.4MQ3 2022: $330.3MQ4 2022: $412.4MQ1 2023: $411.7MQ2 2023: $662.5MQ3 2023: $766.4MQ4 2023: $750.8MQ1 2024: $975.2MQ2 2024: $962.3MQ3 2024: $1.12BQ4 2024: $1.07BQ1 2025: $1.34BQ2 2025: $1.29BQ3 2025: $1.87BQ4 2025: $1.67BQ1 2026: $1.80BQ2 2026: $1.90B
Institutions holding ANIP and their total value by quarter
QuarterHoldersValue
Q2 2026307$1.90B
Q1 2026281$1.80B
Q4 2025285$1.67B
Q3 2025269$1.87B
Q2 2025233$1.29B
Q1 2025231$1.34B
Q4 2024206$1.07B
Q3 2024208$1.12B
Q2 2024201$962.3M
Q1 2024200$975.2M
Q4 2023181$750.8M
Q3 2023186$766.4M
Q2 2023172$662.5M
Q1 2023138$411.7M
Q4 2022126$412.4M
Q3 2022126$330.3M
Q2 2022120$293.4M
Q1 2022126$258.8M
Q4 2021132$413.4M
Q3 2021118$238.8M
Q2 2021116$252.7M
Q1 2021106$263.5M

Institutions, Q1 2025

Shares, value and share of portfolio for each institution holding Ani Pharmaceuticals Inc; share changes are against Q4 2024.

Institutions holding ANIP in Q1 2025
InstitutionSharesValue% of portfolioChange in sharesAction
Royal Bank of Canada210,390$14.1M0.00%+124+0.1%Added
Bank of Montreal215,721$14.4M0.01%−14,432−6.3%Reduced
Northern Trust Corp216,862$14.5M0.00%+12,517+6.1%Added
Nomura Holdings Inc217,176$14.5M0.08%+3,297+1.5%Added
Deutsche Bank AG218,086$14.6M0.01%−14,242−6.1%Reduced
Renaissance Technologies LLC219,502$14.7M0.02%+43,702+24.9%Added
Soleus Capital Management, L.P.224,684$15.0M1.18%+19,390+9.4%Added
D. E. Shaw & Co., Inc.229,701$15.4M0.02%+33,382+17.0%Added
Thompson Siegel & Walmsley LLC237,027$15.9M0.27%−46,833−16.5%Reduced
Charles Schwab Investment Management Inc238,377$16.0M0.00%+2,220+0.9%Added
UBS Group AG264,390$17.7M0.00%−330,420−55.6%Reduced
Kennedy Capital Management, Inc.286,776$19.2M0.46%+100,501+54.0%Added
Tang Capital Management LLC317,500$21.3M1.18%00.0%Unchanged
Ameriprise Financial Inc390,832$26.2M0.01%+119,027+43.8%Added
Standard Life Aberdeen plc419,099$28.1M0.05%+181,134+76.1%Added
JPMorgan Chase & Co422,750$28.3M0.00%+154,700+57.7%Added
Geode Capital Management, LLC429,626$28.8M0.00%+627+0.1%Added
Morgan Stanley437,453$29.3M0.00%+210,875+93.1%Added
Macquarie Group Ltd448,835$30.1M0.04%−113,768−20.2%Reduced
William Blair Investment Management, LLC528,276$35.4M0.10%+43,008+8.9%Added
Ranger Investment Management, L.P.571,638$38.3M2.74%−6,100−1.1%Reduced
Dimensional Fund Advisors LP631,561$42.3M0.01%−54,169−7.9%Reduced
Goldman Sachs Group Inc631,786$42.3M0.01%−67,832−9.7%Reduced
Deep Track Capital, LP700,000$46.9M1.52%+50,958+7.9%Added
State Street Corp714,570$47.8M0.00%−22,718−3.1%Reduced
Citadel Advisors LLC723,329$48.4M0.05%+131,735+22.3%Added
Global Alpha Capital Management Ltd.735,590$49.2M3.58%+111,040+17.8%Added
Millennium Management LLC818,341$54.8M0.05%−184,508−18.4%Reduced
Vanguard Group Inc1,181,471$79.1M0.00%−132,901−10.1%Reduced
BlackRock, Inc.2,646,630$177.2M0.00%−91,942−3.4%Reduced
Stonepine Capital Management, LLC48,000––+27,600+135.3%Added
Healthcare of Ontario Pension Plan Trust Fund0$00.00%−53,100−100.0%Sold out
HRT Financial LP0$00.00%−40,283−100.0%Sold out
Balyasny Asset Management LLC0$00.00%−38,488−100.0%Sold out
Hussman Strategic Advisors, Inc.0$00.00%−31,500−100.0%Sold out
XTX Topco Ltd0$00.00%−18,029−100.0%Sold out
Exchange Traded Concepts, LLC0$00.00%−12,366−100.0%Sold out
Virtus Investment Advisers, Inc.0$00.00%−12,319−100.0%Sold out
SG Americas Securities, LLC0$00.00%−9,843−100.0%Sold out
EntryPoint Capital, LLC0$00.00%−5,947−100.0%Sold out
Integrated Quantitative Investments LLC0$00.00%−4,900−100.0%Sold out
Bridgefront Capital, LLC0$00.00%−3,692−100.0%Sold out
Rafferty Asset Management, LLC0$00.00%−3,622−100.0%Sold out
Pacer Advisors, Inc.0$00.00%−1,827−100.0%Sold out
Lazard Asset Management LLC0$00.00%−1,781−100.0%Sold out
Coppell Advisory Solutions LLC0$00.00%−599−100.0%Sold out
Creative Planning0$00.00%−90−100.0%Sold out
LGT Financial Advisors LLC0$00.00%−58−100.0%Sold out
Parallel Advisors, LLC0$00.00%−36−100.0%Sold out
GeoWealth Management, LLC0$00.00%−19−100.0%Sold out
Elequin Capital LP0$00.00%−2−100.0%Sold out
Nuveen Asset Management, LLC––––Not filed
Virtus Fund Advisers, LLC––––Not filed
Kiely Wealth Advisory Group, Inc.––––Not filed